Relation of advanced cardiovascular-kidney-metabolic syndrome with mortality risk in cancer survivors: joint effect and mediating role of PhenoAge acceleration.
Cancer survivors with both metabolic syndrome and accelerated aging face higher mortality risk; screening both conditions could improve prevention.
This PubMed-indexed study examined relation of advanced cardiovascular-kidney-metabolic syndrome with mortality risk in cancer survivors: joint effect and mediating role of phenoage acceleration. Advanced CKM and PAA were independently associated with mortality, while their coexistence further increased cardiovascular mortality Joint assessment may improve cardiometabolic risk stratification and preventive care.
What the study was
- Study design
- Population-based retrospective cohort study
- Population
- Human participants or human evidence described in the PubMed abstract
- Sample size
- 2781
- Category
- Public Health
- Maturity
- Validated
- Journal
- Diabetes research and clinical practice
Why it surfaced
Population-based retrospective cohort study with PubMed abstract evidence; scored conservatively for public health relevance and evidence maturity.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.